ENTITY

Avenue Therapeutics (ATXI US)

Health CareUnited States
Avenue Therapeutics, Inc. operates as a specialty pharmaceutical company. The Company focuses on the development and commercialization of products principally for use in the acute and hospital setting. Avenue Therapeutics develops an intravenous formulation of tramadol HCI for the treatment of moderate to moderately severe post-operative pain.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x